1. Amos, A. F., McCarty, D. J. & Zimmet, P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med. 14 (Suppl. 5), S1–S85 (1997).
2. Bilous, R. W. & Alberti, K. G. M. M. in New Antidiabetic Drugs (eds Bailey, C. J. & Flat, P. R.) 19–32 (Smith-Gordon and Nishimura, London, United Kingdom and Niigata–Shi, Japan, 1990).
3. Yudkin, J. S. Therapeutic targets for type 2 diabetes post-UKPDS. J. R. Coll. Phys. Lond. 34, 254–256 (2000).
4. Standl, E. Insulin analogues — state of the art. Horm. Res. 57 (Suppl. 1), 40–45 (2002).
5. Owens, D. R. New horizons — alternative routes for insulin therapy. Nature Rev. Drug Discov. 1, 529–540 (2002).